Author Correction: Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis

Affiliations

¹ Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. toni_choueiri@dfci.harvard.edu.
² Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.
³ South Texas Accelerated Research Therapeutics (START), San Antonio, TX, USA.
⁴ Fox Chase Cancer Center, Philadelphia, PA, USA.
⁵ University of Miami, Miami, FL, USA.
⁶ Beth Israel Deaconess Medical Center, Boston, MA, USA.
⁷ Massachusetts General Hospital, Boston, MA, USA.
⁸ University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
⁹ Merck & Co., Inc, Kenilworth, NJ, USA.
¹⁰ The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ejonasch@mdanderson.org.

Published Erratum

Toni K Choueiri et al. Nat Med. 2021 Oct.

. 2021 Oct;27(10):1849.

doi: 10.1038/s41591-021-01516-1.

¹ Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. toni_choueiri@dfci.harvard.edu.
² Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.
³ South Texas Accelerated Research Therapeutics (START), San Antonio, TX, USA.
⁴ Fox Chase Cancer Center, Philadelphia, PA, USA.
⁵ University of Miami, Miami, FL, USA.
⁶ Beth Israel Deaconess Medical Center, Boston, MA, USA.
⁷ Massachusetts General Hospital, Boston, MA, USA.
⁸ University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
⁹ Merck & Co., Inc, Kenilworth, NJ, USA.
¹⁰ The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ejonasch@mdanderson.org.

No abstract available

Erratum for

Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis.
Choueiri TK, Bauer TM, Papadopoulos KP, Plimack ER, Merchan JR, McDermott DF, Michaelson MD, Appleman LJ, Thamake S, Perini RF, Zojwalla NJ, Jonasch E. Choueiri TK, et al. Nat Med. 2021 May;27(5):802-805. doi: 10.1038/s41591-021-01324-7. Epub 2021 Apr 22. Nat Med. 2021. PMID: 33888901 Free PMC article. Clinical Trial.